Emergent BioSolutions Inc. - Common Stock (EBS)
CUSIP: 29089Q105
Q2 2016 13F Holders as of 30 Jun 2016
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 52,021,849
- Total 13F shares
- 36,161,934
- Share change
- +3,064,625
- Total reported value
- $1,016,934,072
- Put/Call ratio
- 536%
- Price per share
- $28.12
- Number of holders
- 215
- Value change
- +$82,512,424
- Number of buys
- 132
- Number of sells
- 88
Quarterly Holders Quick Answers
What is CUSIP 29089Q105?
CUSIP 29089Q105 identifies EBS - Emergent BioSolutions Inc. - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 29089Q105:
Top shareholders of EBS - Emergent BioSolutions Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| VANGUARD GROUP INC |
13F
|
Company |
6.1%
|
3,194,662
|
$116,127,000 | — | 31 Mar 2016 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
4%
|
2,061,744
|
$74,943,000 | — | 31 Mar 2016 | |
| BlackRock Fund Advisors |
13F
|
Company |
3.6%
|
1,890,512
|
$68,720,000 | — | 31 Mar 2016 | |
| ACADIAN ASSET MANAGEMENT LLC |
13F
|
Company |
3.1%
|
1,587,203
|
$57,694,000 | — | 31 Mar 2016 | |
| Bank of New York Mellon Corp |
13F
|
Company |
2.6%
|
1,353,021
|
$49,182,000 | — | 31 Mar 2016 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
2.1%
|
1,112,811
|
$40,451,000 | — | 31 Mar 2016 | |
| STATE STREET CORP |
13F
|
Company |
2.1%
|
1,099,602
|
$39,969,000 | — | 31 Mar 2016 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
1.7%
|
891,876
|
$32,420,000 | — | 31 Mar 2016 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
1.6%
|
846,625
|
$30,775,000 | — | 31 Mar 2016 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.6%
|
810,430
|
$29,459,000 | — | 31 Mar 2016 | |
| MANUFACTURERS LIFE INSURANCE COMPANY, THE |
13F
|
Company |
1.6%
|
831,340
|
$29,279,000 | — | 31 Mar 2016 | |
| GLENMEDE TRUST CO NA |
13F
|
Company |
1.4%
|
748,557
|
$27,208,000 | — | 31 Mar 2016 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
1.2%
|
614,560
|
$22,337,000 | — | 31 Mar 2016 | |
| FMR LLC |
13F
|
Company |
1%
|
542,741
|
$19,729,000 | — | 31 Mar 2016 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
1%
|
527,351
|
$19,170,000 | — | 31 Mar 2016 | |
| FIDUCIARY MANAGEMENT ASSOCIATES LLC |
13F
|
Company |
0.99%
|
516,949
|
$18,793,000 | — | 31 Mar 2016 | |
| GUGGENHEIM CAPITAL LLC |
13F
|
Company |
0.99%
|
516,784
|
$18,785,000 | — | 31 Mar 2016 | |
| Fisher Asset Management, LLC |
13F
|
Company |
0.88%
|
457,742
|
$18,127,000 | — | 31 Mar 2016 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.95%
|
493,659
|
$17,932,000 | — | 31 Mar 2016 | |
| ABERDEEN ASSET MANAGEMENT PLC/UK |
13F
|
Company |
0.93%
|
482,252
|
$17,530,000 | — | 31 Mar 2016 | |
| RUSSELL FRANK CO/ |
13F
|
Company |
0.88%
|
458,398
|
$16,663,000 | — | 31 Mar 2016 | |
| Gotham Asset Management, LLC |
13F
|
Company |
0.85%
|
443,728
|
$16,130,000 | — | 31 Mar 2016 | |
| AJO, LP |
13F
|
Company |
0.82%
|
427,933
|
$15,555,000 | — | 31 Mar 2016 | |
| EAGLE ASSET MANAGEMENT INC |
13F
|
Company |
0.81%
|
419,287
|
$15,241,000 | — | 31 Mar 2016 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.74%
|
382,756
|
$13,913,000 | — | 31 Mar 2016 | |
| Invesco Ltd. |
13F
|
Company |
0.68%
|
354,188
|
$12,875,000 | — | 31 Mar 2016 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.61%
|
314,953
|
$11,448,000 | — | 31 Mar 2016 | |
| SNYDER CAPITAL MANAGEMENT L P |
13F
|
Company |
0.59%
|
305,614
|
$11,109,000 | — | 31 Mar 2016 | |
| RICE HALL JAMES & ASSOCIATES, LLC |
13F
|
Company |
0.53%
|
275,297
|
$10,007,000 | — | 31 Mar 2016 | |
| Pine River Capital Management L.P. |
13F
|
Company |
0.52%
|
270,990
|
$9,851,000 | — | 31 Mar 2016 | |
| TEACHERS ADVISORS, LLC |
13F
|
Company |
0.51%
|
267,195
|
$9,713,000 | — | 31 Mar 2016 | |
| PARAMETRIC PORTFOLIO ASSOCIATES LLC |
13F
|
Company |
0.44%
|
227,989
|
$8,287,000 | — | 31 Mar 2016 | |
| FEDERATED HERMES, INC. |
13F
|
Company |
0.44%
|
226,480
|
$8,233,000 | — | 31 Mar 2016 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
0.43%
|
224,541
|
$8,162,000 | — | 31 Mar 2016 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.42%
|
217,017
|
$7,888,000 | — | 31 Mar 2016 | |
| LSV ASSET MANAGEMENT |
13F
|
Company |
0.41%
|
211,997
|
$7,706,000 | — | 31 Mar 2016 | |
| PRINCIPAL FINANCIAL GROUP INC |
13F
|
Company |
0.41%
|
211,606
|
$7,692,000 | — | 31 Mar 2016 | |
| Matarin Capital Management, LLC |
13F
|
Company |
0.4%
|
209,517
|
$7,615,943 | — | 31 Mar 2016 | |
| MUTUAL OF AMERICA CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.39%
|
203,789
|
$7,408,000 | — | 31 Mar 2016 | |
| INSIGHT CAPITAL RESEARCH & MANAGEMENT INC |
13F
|
Company |
0.39%
|
203,367
|
$7,392,000 | — | 31 Mar 2016 | |
| PUBLIC EMPLOYEES RETIREMENT ASSOCIATION OF COLORADO |
13F
|
Company |
0.39%
|
202,392
|
$7,357,000 | — | 31 Mar 2016 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
0.36%
|
188,150
|
$6,839,000 | — | 31 Mar 2016 | |
| PRUDENTIAL FINANCIAL INC |
13F
|
Company |
0.36%
|
185,497
|
$6,743,000 | — | 31 Mar 2016 | |
| NORGES BANK |
13F
|
Company |
0.35%
|
180,400
|
$6,558,000 | — | 31 Mar 2016 | |
| AMERICAN CENTURY COMPANIES INC |
13F
|
Company |
0.34%
|
178,057
|
$6,472,000 | — | 31 Mar 2016 | |
| MILLENNIUM MANAGEMENT LLC |
13F
|
Company |
0.33%
|
171,557
|
$6,236,000 | — | 31 Mar 2016 | |
| QS Investors, LLC |
13F
|
Company |
0.33%
|
169,643
|
$6,167,000 | — | 31 Mar 2016 | |
| OXFORD ASSET MANAGEMENT LLP |
13F
|
Company |
0.31%
|
162,397
|
$5,903,000 | — | 31 Mar 2016 | |
| STRS OHIO |
13F
|
Company |
0.3%
|
157,900
|
$5,739,000 | — | 31 Mar 2016 | |
| Employees Retirement System of Texas |
13F
|
Company |
0.29%
|
149,000
|
$5,416,000 | — | 31 Mar 2016 |
Institutional Holders of Emergent BioSolutions Inc. - Common Stock (EBS) as of Q2 2016
As of 30 Jun 2016,
Emergent BioSolutions Inc. - Common Stock (EBS) was held by
215 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
36,161,934 shares.
The largest 10 holders included
VANGUARD GROUP INC, DIMENSIONAL FUND ADVISORS LP, BlackRock Fund Advisors, ACADIAN ASSET MANAGEMENT LLC, RENAISSANCE TECHNOLOGIES LLC, STATE STREET CORP, GLENMEDE TRUST CO NA, BlackRock Institutional Trust Company, N.A., D. E. Shaw & Co., Inc., and GOLDMAN SACHS GROUP INC.
This page lists
215
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q2 2016 vs Q1 2016 Across Filers
Q1 2016 holders
211
Q2 2016 holders
215
Holder diff
4
| Investor | Q1 2016 Shares | Q2 2016 Shares | Share Diff | Share Chg % | Q1 2016 Value $ | Q2 2016 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.